A Clinical Study to Explore CT1195E in Patients With Relapsed/Refractory B-Cell Neoplasms
Clinical trial NCT07234045 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07234045
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-30
- Primary completion
- 2027-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.